DiaMedica Therapeutics Inc.
Company Stats
- Market Cap
- $446.0M
- as of Sep 30, 2026
- Shares Outstanding
- 53.9M
- Free Float
- 42.6%
Income Statement
- Operating Income
- -$34.4M
- Net Income
- -$32.8M
- EBITDA
- -$34.4M
Cash Flow
- Free Cash Flow
- -$29.1M
- FCF Yield
- -6.5%
- Owner FCF Yield
- -7.4%
Balance Sheet
- Cash & Equivalents
- $15.6M
Returns & Capital
- SBC, 3Y Avg
- $2.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$29.1M | — |
| FY2024 | — | -$22.1M | — |
| FY2023 | — | -$18.8M | — |
| FY2022 | — | -$11.6M | — |
| FY2021 | — | -$12.3M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges